Findings captured during emergency scans intended to pinpoint stroke can reveal viral infection.
CT scans conducted in the emergency department on patients suspected of having a stroke may also identify individuals who are infected with SARS-CoV-2, the virus that causes COVID-19.
Based on the examination of patients from three London Hyper-Acute Stroke Units, a team of researchers from King’s College London determined carotid CTA scans of the head and neck blood vessels can accurately reveal patients who should subsequently be tested for the virus.
The team published their results in the Sept. 17 American Journal of Neuroradiology.
“Early identification of patients with COVID-19 is essential for treatment and viral control,” said the team led by Tom Booth, Ph.D., senior lecturer in neuroimaging at Kings College. “Therefore, the search for alternative diagnostic biomarkers for COVID-19 is mandated in the context of asymptomatic and pre-symptomatic infection and the variable sensitivity of SARS-CoV-2 RT-PCR testing.”
At the time the CTA scans were conducted, the team pointed out, only 15 percent of RT-PCR results were complete. The slow rate of return underscores the need for reliable alternative diagnostic COVID-19 biomarkers.
By analyzing scans from 225 patients who were initially examined for possible stroke, the team noticed ground glass opacities (GGO) in the tops of the lungs caught on the emergency images in 22.2 percent of patients. Compared with RT-PRC results, the diagnostic performance was strong – 75 percent sensitivity and 81 percent specificity. The team also determined that GGO at the top of the lungs was an independent predictor of increased 30-day mortality.
The team referred to GGO identified on a CTA scan as “free information” since it can be gleaned from an image intended for a different diagnostic purpose.
Related Content: Abdominal Radiologists Stay Alert: Some COVID-19 Patients Present with GI Symptoms Only
These results expand the type of exams radiologists can use to identify more patients who are positive for COVID-19 but who do not present to the hospital with characteristic symptoms of the virus as their major complaint. A recent study published in Abdominal Radiology detailed that evidence of COVID-19 infection can also be found in the bottom of the lungs captured in abdominal CT scans.
Alongside identifying the patients who will need additional medical services, the team said, these findings can be used to help staff prevent avoidable exposures.
“The implications of our findings plausibly include earlier selection of the appropriate level of personal protective equipment and attendant staff numbers, triage to appropriate inpatient ward settings, self-isolation, and contact tracing,” the team explained. “Biomarkers, such as a scan positive for GGO, should heighten awareness of a potential positive case, possibly changing staff personal protective equipment requirements and also directing a patient to a side room instead of an open ward, pending RT-PCR results.”
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.